Market Value2,434,834,304
Total Holdings58
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GERN / Geron Corporation
IONS / Ionis Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
BEAM / Beam Therapeutics Inc.
ETNB / 89bio, Inc. Put
BMRN / BioMarin Pharmaceutical Inc.
FULC / Fulcrum Therapeutics, Inc.
NKTX / Nkarta, Inc.
NTLA / Intellia Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
ALKS / Alkermes plc
IPSC / Century Therapeutics, Inc.
RPTX / Repare Therapeutics Inc.
IMGN / ImmunoGen, Inc. Put
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
SNDX / Syndax Pharmaceuticals, Inc.
HZNP / Horizon Therapeutics Plc
HZNP / Horizon Therapeutics Plc Put
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
RNA / Avidity Biosciences, Inc.
DVAX / Dynavax Technologies Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
/ Third Harmonic Bio, Inc.
TSVT / 2seventy bio, Inc.
DICE / DICE Therapeutics Inc
EXEL / Exelixis, Inc.
ISEE / IVERIC bio Inc
CRNX / Crinetics Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock) Put
BIIB / Biogen Inc.
VIGL / Vigil Neuroscience, Inc.
IMVT / Immunovant, Inc.
DYN / Dyne Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
JAZZ / Jazz Pharmaceuticals plc
PACB / Pacific Biosciences of California, Inc.
GHRS / GH Research PLC
INSM / Insmed Incorporated
SRPT / Sarepta Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
ASMB / Assembly Biosciences, Inc.
ALBO / Albireo Pharma Inc
AUPH / Aurinia Pharmaceuticals Inc.
HOOK / HOOKIPA Pharma Inc.
NKTR / Nektar Therapeutics
JNCE / Jounce Therapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A Call
EWTX / Edgewise Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
IMUX / Immunic, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
MGTA / Magenta Therapeutics Inc
SGEN / Seagen Inc Put
PTGX / Protagonist Therapeutics, Inc.
PNT / POINT Biopharma Global Inc.
ABOS / Acumen Pharmaceuticals, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
ACRS / Aclaris Therapeutics, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
RLMD / Relmada Therapeutics, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
NUVB / Nuvation Bio Inc.
AGEN / Agenus Inc.
NRIX / Nurix Therapeutics, Inc.
ETNB / 89bio, Inc.
PLRX / Pliant Therapeutics, Inc.
ESPR / Esperion Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
ALLK / Allakos Inc.
INZY / Inozyme Pharma, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.